Oric Pharmaceuticals (ORIC) Other financing activities (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Other financing activities of $1.3 million for Q1 2026, up 32.63% on a QoQ basis from $944000.0 in Q4 2025, and up 394.86% year-over-year from $253000.0 in Q1 2025.
Oric Pharmaceuticals (ORIC) Other financing activities (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Other financing activities history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Other financing activities rose 394.86% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 334.11% YoY) and the FY2025 annual result came in at $2.0 million, up 213.63% from the prior year.
- Other financing activities was $1.3 million for Q1 2026 at Oric Pharmaceuticals, up from $944000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.3 million in Q1 2026 and bottomed at $1000.0 in Q3 2022.
- A 5-year average of $266666.7 and a median of $61000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 99.88% — and 2025, when it soared 6642.86%.
- Oric Pharmaceuticals' Other financing activities stood at $1000.0 in 2022, then surged by 2700.0% to $28000.0 in 2023, then plunged by 50.0% to $14000.0 in 2024, then surged by 6642.86% to $944000.0 in 2025, then soared by 32.63% to $1.3 million in 2026.
- Business Quant data shows ORIC's Other financing activities at $1.3 million in Q1 2026, $944000.0 in Q4 2025, and $748000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 944,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 293,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |